SCHEMBL4656018

SCHEMBL4656018

N#CC(C#N)=Cc1c(Cl)cc(C(F)(F)F)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
MAPT P10636 7/20 0.43
KDM4E B2RXH2 5/20 0.43
NPSR1 Q6W5P4 4/20 0.43
TRPA1 O75762 1/20 0.41
RPS6KA3 P51812 1/20 0.41
JAK3 P52333 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.38
HTT P42858 2/20 0.38
KMT2A Q03164 6/20 0.36
MEN1 O00255 5/20 0.36
LMNA P02545 5/20 0.36
POLB P06746 1/20 0.36
EGFR P00533 3/20 0.36
TP53 P04637 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2C9 P11712 3/20 0.35
HPGD P15428 3/20 0.35
ALOX15 P16050 3/20 0.35
TSHR P16473 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1930658 0.79 TRPA1 (0.47) ALDH1A1MAPTKDM4ENPSR1TRPA1
SCHEMBL15298123 0.78 TRPA1 (0.53) ALDH1A1MAPTKDM4ENPSR1TRPA1
SCHEMBL10619593 0.72 ALDH1A1 (0.39) ALDH1A1MAPTKDM4ENPSR1RPS6KA3
SCHEMBL6839476 0.71 TRPA1 (0.62) ALDH1A1MAPTKDM4ENPSR1TRPA1
SCHEMBL3198319 0.69 GAA (0.50) ALDH1A1MAPTKDM4ENPSR1RPS6KA3
SCHEMBL3198314 0.69 GAA (0.50) ALDH1A1MAPTKDM4ENPSR1RPS6KA3
SCHEMBL424091 0.69 ALDH1A1 (0.44) ALDH1A1MAPTKDM4EHTTKMT2A
SCHEMBL4741271 0.69 GABRB3 (0.47) ALDH1A1KDM4ESMN1; SMN2HTTKMT2A
SCHEMBL3369087 0.68 MAPT (0.68) ALDH1A1MAPTKDM4ENPSR1SMN1; SMN2
SCHEMBL15298179 0.68 ALDH1A1 (0.50) ALDH1A1MAPTKDM4ENPSR1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385817-B1 MALONONITRILE COMPOUNDS AND THEIR USE AS PESTICIDES SUMITOMO CHEMICAL CO (JP) 2008-12-03 EP disclosed
US-7402691-B2 Malononitrile compounds and their use as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-07-22 US disclosed
US-7011838-B2 Malononitrile compounds and their use as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-03-14 US disclosed
US-20050209323-A1 Malononitrile compounds and their use as pesticides OTAKA KEN 2005-09-22 US disclosed
US-20040138065-A1 Malononitrile compounds and their use as pesticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209323-A1 Malononitrile compounds and their use as pesticides C1S, C1R, C5 ALDH1A1 1502/4885MAPT 4314/4885KDM4E 1754/4885
US-20040138065-A1 Malononitrile compounds and their use as pesticides CBR1, MAL2, CBR3 ALDH1A1 614/4885MAPT 4612/4885KDM4E 1181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.